a new society for life sciences

On August 10, Alphabet, the new Google holding company, was announced to manage all of the activities of the American giant. A few days ago, Sergey Brin, the co-founder of the company announced the creation of a new biotechnology subsidiary, which will bring together some of the researchers who are members of Google X.

"(…) I am delighted to announce that the life sciences team is now ready to move from our X lab to an autonomous Alphabet business, with Andy Conrad as CEO", announced Sergey Brin on his Google + account. This independent biotechnology subsidiary should focus on health technologies, with the mission of “develop new technologies to make health care more proactive“, Explains the co-founder of the American giant. "We hope transform the way we can detect, prevent and manage disease“, He continues. At the center of this research, nanoparticles which should make it possible to detect diseases very early.

If the life sciences take their independence, Sergey Brin ensures that the objectives assigned remain the same. Software engineers, oncologists, and optical experts should join the researchers to “pass on new technologies from the early stage of R&D to clinical trials". With this new subsidiary, we should expect to see the emergence and realization of projects as ambitious and revolutionary as the smart contact lenses already developed by researchers. These should indeed help people with diabetes, by continuously measuring the glucose level present in their tear fluid.

Source

[ad_2]